Form 4 for DGX Quest Diagnostics
Accepted 2023-03-08 00:00:00 ET · period of report 2023-03-06 · accession 0001022079-23-000065 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2023-03-08 | 2023-03-06 | DGX | Davis J. E. | CEO, Pres, Dir | A - Grant | $147.86 | +15.2K | 110.7K | +16% | +$2.25M | |
| 2023-03-08 | 2023-03-06 | DGX | Davis J. E. | CEO, Pres, Dir | F - Tax | $147.86 | -8,036 | 102.6K | -7% | -$1.19M |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2023-03-06 | A | A | 15,204 | $147.86 | 110,670 | D | — | — | |
| 2 | Common | Common Stock | 2023-03-06 | F | D | 8,036 | $147.86 | 102,634 | D | — | — |